Synthetic peptide derived from human Ephrin-B1/2/3 around Tyr324
Reactivity
Human, mouse, rat
Applications
Western blot (WB), immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA)
Clonality
Polyclonal
Conjugate
Non-conjugated
Storage
-20°C or -80°C; avoid repeated freeze-thaw cycles
Biological Role of Tyr324 Phosphorylation
Phosphorylation at Tyr324 is critical for regulating Ephrin-B protein interactions with Eph receptors, which mediate cell signaling pathways involved in:
Axon guidance and neuronal development.
Cell adhesion and migration during tissue morphogenesis.
Viral entry, as Ephrin-B2 (EFNB2) serves as a receptor for Nipah and Hendra viruses.
This modification enhances Ephrin-B receptor binding specificity, enabling precise signaling during development and immune responses.
Western Blot
Detects phosphorylated Ephrin-B proteins in lysates (e.g., K562 cells treated with serum).
Recommended dilutions: 1:500–1:2000.
Immunohistochemistry
Stains phosphorylated Ephrin-B in paraffin-embedded tissues (e.g., human brain).
Dilutions: 1:100–1:300.
ELISA
Quantifies phosphorylated Ephrin-B levels in cell lysates or biological fluids.
Dilution: 1:20,000.
Key Research Findings
Viral Entry Mechanisms
EFNB2 phosphorylation at Tyr324 enhances binding to Nipah virus G glycoprotein, facilitating viral entry.
Engineered soluble Ephrin-B2 decoys (e.g., sEFNB2-Fc) inhibit henipavirus infection by competing for viral attachment.
Immune Cell Development
Ephrin-B1 marks mature germinal center B cells during immune responses, distinguishing them from transitional populations.
Phosphorylation at Tyr324 correlates with Ephrin-B1 expression in plasma cells and memory B cells.
Cancer Research
Dysregulated Ephrin-B signaling is implicated in tumor progression and metastasis, making Tyr324 phosphorylation a potential therapeutic target.
Therapeutic Implications
The antibody’s specificity for phosphorylated Ephrin-B proteins supports research into:
Antiviral therapies: Engineering Ephrin-B decoys to block viral entry.
Cancer treatments: Targeting Ephrin-B signaling pathways to inhibit tumor growth.
Neurological disorders: Investigating Ephrin-B phosphorylation in neurodegenerative diseases.
Product Specs
Buffer
The antibody is provided as a liquid solution in phosphate-buffered saline (PBS) containing 50% glycerol, 0.5% bovine serum albumin (BSA), and 0.02% sodium azide.
Form
Liquid
Lead Time
We typically dispatch orders within 1-3 business days of receipt. Delivery times may vary depending on the purchase method and location. Please contact your local distributor for specific delivery timelines.